Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Serina Therapeutics (SER) EPS (Weighted Average and Diluted) (2021 - 2025)

Historic EPS (Weighted Average and Diluted) for Serina Therapeutics (SER) over the last 5 years, with Q3 2025 value amounting to -$0.45.

  • Serina Therapeutics' EPS (Weighted Average and Diluted) fell 44615.38% to -$0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.87, marking a year-over-year increase of 5917.03%. This contributed to the annual value of -$2.39 for FY2024, which is 42713.65% down from last year.
  • According to the latest figures from Q3 2025, Serina Therapeutics' EPS (Weighted Average and Diluted) is -$0.45, which was down 44615.38% from -$0.66 recorded in Q2 2025.
  • In the past 5 years, Serina Therapeutics' EPS (Weighted Average and Diluted) registered a high of $0.51 during Q2 2024, and its lowest value of -$9.5 during Q4 2022.
  • Over the past 5 years, Serina Therapeutics' median EPS (Weighted Average and Diluted) value was -$0.06 (recorded in 2022), while the average stood at -$1.01.
  • As far as peak fluctuations go, Serina Therapeutics' EPS (Weighted Average and Diluted) surged by 48333.33% in 2023, and later crashed by 279000.0% in 2024.
  • Over the past 5 years, Serina Therapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.0 in 2021, then crashed by 347885.92% to -$9.5 in 2022, then soared by 101.68% to $0.16 in 2023, then crashed by 572.72% to -$0.76 in 2024, then soared by 40.5% to -$0.45 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.45 for Q3 2025, versus -$0.66 for Q2 2025 and -$0.49 for Q1 2025.